PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group
Summary Response Assessment in Neuro-Oncology (RANO) response criteria have been
established and were updated in 2023 for MRI-based response evaluation of diffuse …
established and were updated in 2023 for MRI-based response evaluation of diffuse …
Current status of PET imaging in neuro-oncology
Over the past decades, a variety of PET tracers have been used for the evaluation of patients
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …
with brain tumors. For clinical routine, the most important clinical indications for PET imaging …
FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation
Simple Summary Following chemoradiation with alkylating agents in glioma patients,
structural magnetic resonance imaging (MRI) may suggest tumor progression which …
structural magnetic resonance imaging (MRI) may suggest tumor progression which …
Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre …
Abstract Purpose The O-(2-[18F]-fluoroethyl)-l-tyrosine (FET) PET in Glioblastoma (FIG) trial
is an Australian prospective, multi-centre study evaluating FET PET for glioblastoma patient …
is an Australian prospective, multi-centre study evaluating FET PET for glioblastoma patient …
Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy
Immunotherapy has become a fourth pillar in the treatment of brain tumors and, when
combined with radiation therapy, may improve patient outcomes and reduce the …
combined with radiation therapy, may improve patient outcomes and reduce the …
Amino acid PET in neurooncology
For decades, several amino acid PET tracers have been used to optimize diagnostics in
patients with brain tumors. In clinical routine, the most important clinical indications for amino …
patients with brain tumors. In clinical routine, the most important clinical indications for amino …
Advanced imaging techniques for radiotherapy planning of gliomas
A Castellano, M Bailo, F Cicone, L Carideo… - Cancers, 2021 - mdpi.com
Simple Summary Conventional magnetic resonance imaging (MRI) sequences have known
limitations in target delineation for radiation treatment (RT) planning of cerebral gliomas …
limitations in target delineation for radiation treatment (RT) planning of cerebral gliomas …
High-grade glioma treatment response monitoring biomarkers: a position statement on the evidence supporting the use of advanced MRI techniques in the clinic, and …
TC Booth, EC Wiegers, EAH Warnert… - Frontiers in …, 2022 - frontiersin.org
Objective To summarize evidence for use of advanced MRI techniques as monitoring
biomarkers in the clinic, and to highlight the latest bench-to-bedside developments. Methods …
biomarkers in the clinic, and to highlight the latest bench-to-bedside developments. Methods …
Early treatment response assessment using 18F-FET PET compared with contrast-enhanced MRI in glioma patients after adjuvant temozolomide chemotherapy
The goal of this study was to compare the value of contrast-enhanced MRI and O-(2-[18F]
fluoroethyl)-l-tyrosine (18F-FET) PET for response assessment in glioma patients after …
fluoroethyl)-l-tyrosine (18F-FET) PET for response assessment in glioma patients after …
Assessment and prediction of glioblastoma therapy response: challenges and opportunities
Glioblastoma is the most aggressive type of primary adult brain tumour. The median survival
of patients with glioblastoma remains approximately 15 months, and the 5-year survival rate …
of patients with glioblastoma remains approximately 15 months, and the 5-year survival rate …